Get started
Author

Ronac Mamtani

Observed names: Mamtani, R., Mamtani, Ronac, R Mamtani, R. Mamtani
Observed institutions: Ben-Gurion University of the Negev, Eisenhower Medical Center, Children's Hospital of Philadelphia, NewYork–Presbyterian Hospital, Penn Presbyterian Medical Center, Johns Hopkins University, Thomas Jefferson University, Tel Aviv University, Pfizer (United States), New York Medical College, Columbia University Irving Medical Center, Tel Aviv Sourasky Medical Center, Hospital of the University of Pennsylvania, Sheba Medical Center, Yale University, VA Connecticut Healthcare System, Stony Brook School, Bristol-Myers Squibb (United States), Calvary Hospital, Stony Brook Medicine, James J. Peters VA Medical Center, Calvary Hospital, Philadelphia VA Medical Center, University of Pennsylvania Health System, Flatiron Health (United States), Sidney Kimmel Comprehensive Cancer Center, Abramson Cancer Center, Merck Healthcare KGaA, Darmstadt (Germany), Leonard Davis Institute of Health Economics, Weill Cornell Medical Center, Stony Brook University, University of Pennsylvania
ORCID: 0000-0002-8267-5356
Observed ORCID: 0000-0002-8267-5356
OpenAlex ID: A5055266545
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
2020 · Erez N. Baruch, Ilan Youngster, et al. · Science · 1,734
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
2009 · Kenneth R. Carson, Andrew M. Evens, et al. · Blood · 866
PDF
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
2021 · Thomas Powles, Tibor Csőszi, et al. · The Lancet Oncology · 642
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
2021 · Erin M. Bange, Nicholas A. Han, et al. · Nature Medicine · 520
PDF
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
2015 · James D. Lewis, Laurel A. Habel, et al. · JAMA · 321
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
2022 · Thomas W. Flaig, Philippe E. Spiess, et al. · Journal of the National Comprehensive Cancer Network · 296
PDF
Bladder Cancer, Version 3.2024
2024 · Thomas W. Flaig, Philippe E. Spiess, et al. · Journal of the National Comprehensive Cancer Network · 273
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
2015 · Ben Boursi, Ronac Mamtani, et al. · European Journal of Cancer · 263
Antibiotic Exposure and the Risk for Depression, Anxiety, or Psychosis
2015 · Ido Lurie, Yu-Xiao Yang, et al. · The Journal of Clinical Psychiatry · 230
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes
2016 · Ben Boursi, Brian Finkelman, et al. · Gastroenterology · 202
Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity
2016 · Frank I. Scott, Daniel B. Horton, et al. · Gastroenterology · 192
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
2015 · Frank I. Scott, Ronac Mamtani, et al. · JAMA Dermatology · 180
PDF
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
2023 · J.E. Rosenberg, T. Powles, et al. · Annals of Oncology · 171
PDF
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung Cancer
2023 · Lova Sun, Benjamin Bleiberg, et al. · JAMA Oncology · 162
PDF
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
2016 · Edward Shelton, David Laharie, et al. · Gastroenterology · 153
Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
2018 · James D Lewis, Frank I Scott, et al. · The American Journal of Gastroenterology · 151
The effect of past antibiotic exposure on diabetes risk
2015 · Ben Boursi, Ronac Mamtani, et al. · European Journal of Endocrinology · 150
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
2023 · Matthew D. Galsky, Siamak Daneshmand, et al. · Nature Medicine · 144
PDF
Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer
2020 · Samuel U. Takvorian, Arman Oganisian, et al. · JAMA Network Open · 143
PDF
Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score–matched analysis
2015 · Brett L. Ecker, Matthew T. McMillan, et al. · Cancer · 121
PDF
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
2012 · Ronac Mamtani, Kevin Haynes, et al. · JNCI Journal of the National Cancer Institute · 119
PDF
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018 · Joshua M Bauml, Ravi Vinnakota, et al. · JNCI Journal of the National Cancer Institute · 112
PDF
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
2017 · Kim A. Reiss, Shun Yu, et al. · Journal of Clinical Oncology · 99
Impact of antibiotic exposure on the risk of colorectal cancer
2015 · Ben Boursi, Kevin Haynes, et al. · Pharmacoepidemiology and Drug Safety · 89
PDF
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
2021 · Lova Sun, Miles Hsu, et al. · JAMA Oncology · 87
PDF
Works count: 371
Citation count: 11,500
H-index: 46
I10-index: 124
Year
Topic
Type